Serial Monitoring of Circulating Melanoma Cells During Neoadjuvant Biochemotherapy for Stage III Melanoma: Outcome Prediction in a Multicenter Trial

PURPOSE: Circulating tumor cells (CTCs) in blood may be important in assessing tumor progression and treatment response. We hypothesized that quantitative real-time reverse transcriptase polymerase chain reaction using multimarker mRNA assays could detect CTCs and be used as a surrogate predictor of...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Koyanagi, Kazuo, O’Day, Steven J., Gonzalez, Rene, Lewis, Karl, Robinson, William A., Amatruda, Thomas T., Wang, He-Jing, Elashoff, Robert M., Takeuchi, Hiroya, Umetani, Naoyuki, Hoon, Dave S.B.
Format: Artigo
Jezik:Inglês
Izdano: 2005
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2856446/
https://ncbi.nlm.nih.gov/pubmed/16258104
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2005.02.0958
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items